Clinical trials
Phase 1 Non-alcoholic Fatty Liver Disease trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eccogene | 4 |
| Altimmune, Inc. | 2 |
| Bird Rock Bio, Inc. | 1 |
| Blade Therapeutics | 1 |
| Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 1 |
| Enyo Pharma | 1 |
| Inipharm Australia Pty Ltd | 1 |
| JD Bioscience Inc. | 1 |
| LISCure Biosciences | 1 |
| NGM Biopharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 17 |
| Obesity | 3 |
| Arthritis, Rheumatoid | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Osteoarthritis | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.